Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia  

作　　者：周励 

机构地区：[1]Dept Hematol,Shanghai Instit Hematol,Ruijin Hosp,Shanghai Jiaotong Univ Med Sch

出　　处：《China Medical Abstracts(Internal Medicine)》2013年第2期123-123,共1页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To compare the efficacy and safety of dasatinib and imatinib in patients with newly diagnosed chronic phase chronic myeloid leukemia(CML-CP).Methods37CML-CP patients were randomized to

关 键 词：MYELOID cumulative PLEURAL median mostly EDEMA versus EFFUSION option statistic 

分 类 号：R733.7[医药卫生—肿瘤]